SQUAWK/NEWS
Account
Theme
Account
Menu
Live News EQUITY FLASH L impact

Contineum Therapeutics Expected to Post 45-Cent Per-Share Loss

An earnings preview expects Contineum Therapeutics to report a loss of 45 cents per share.

CTNM

Related stories